LIVE
Live GMP data updating in real-timeTrack every Indian IPO — Open, Upcoming & ClosedGrey Market Premium updated multiple times dailySubscription ratios refreshed throughout active IPO windowsLive GMP data updating in real-timeTrack every Indian IPO — Open, Upcoming & ClosedGrey Market Premium updated multiple times dailySubscription ratios refreshed throughout active IPO windows
Bio Medica Laboratories Ltd
Closed BSE SME Bookbuilding IPO

Bio Medica Laboratories Ltd IPO

GMP Today
+₹2
+1%
Issue Price
₹139
Est. Listing: ₹141
IPO Overview
Quick facts
Issue Price
₹139
Lot Size
1,000 shares
Min. Investment
₹139,000
Issue Size
37,72,000 shares (agg. up to ₹52 Cr)
Face Value
₹10
Issue Type
Bookbuilding IPO
Listing Exchange
BSE SME
Script Code
Important Dates
IPO Open
21 May 2026
Done
IPO Close
25 May 2026
Done
Allotment
26 May 2026
Done
Refund Init.
27 May 2026
Done
Demat Credit
27 May 2026
Done
Listing Date
29 May 2026
Done
Bio Medica Laboratories Ltd Stock Price
BSE
Open
High
Low
Loading chart…
Chart data unavailable
Data via Yahoo Finance · For informational use only
Subscription Allocation
Category Shares Offered Lots Amount (₹)
QIB (Qualified Institutional) 36000 ₹—
NII / HNI (Non-Institutional) 1755000 3 ₹4,17,000
Retail (Individual) 1792000 2 ₹2,78,000
Market Maker 1,89,000 ₹—
Fresh Issue 32,06,000 shares (agg. up to ₹45 Cr) ₹—
OFS (Offer for Sale) 3,77,000 shares of ₹10 (agg. up to ₹5 Cr) ₹—
Minimum Application Size
Investor Type Lots Shares Amount (₹)
Retail (Min 1 Lot) 2 2,000 ₹2,78,000
HNI — sHNI 3 3,000 ₹4,17,000
Subscription Status
Final
Metric QIB NII Retail Total
Subscription 15.94 1.30 2.92 2.26
Shares 36000 1755000 1792000 3583000
Bids 574000 2286000 5228000 8088000
Financial Highlights

Amount in ₹ Crore

Metric 30 Nov 2025 31 Mar 2025 31 Mar 2024
Revenue 283815
PAT 892
EBITDA 13155
Net Worth 17144
Total Assets 653919
Reserves 754
Borrowings 381510
ROE
54
ROCE
23
RONW
54
PAT Margin
30
EBITDA Mgn
47
D/E Ratio
2
Pre EPS
10
Post EPS
10
Pre P/E
13
Post P/E
13
Objects of Issue
  • Repayment of loan
  • Enhancement of its existing production capabilities by setting up of new manufacturing facility at the existing premises
  • General Corporate Purposes
  • {"object":null,"expected_amount":null}
About Bio Medica Laboratories Ltd

Incorporated in August 2015, Bio Medica Laboratories specialises in manufacturing pharmaceutical parenteral formulations, producing a wide range of ethical drugs, generic drugs, and over-the-counter (OTC) medications in liquid and dry-powder injectable forms.der injectables. These injectables are available in both single-dose and multi-dose formats, serving the needs of both human and veterinary healthcare.

Product portfolio:

  • Liquid Injectables: 58 products are offered under this category
  • Dry powder injectables: 15 products under this category

It offers comprehensive range of products, including generic drugs, branded pharmaceuticals, over the counter (OTC) products, and other medications.

The company operates on a B2B model, focusing exclusively on contract manufacturing. It develop formulations for various companies in accordance with their specific requirements and product specifications. It is certified for Good Manufacturing Practices (GMP) and Good Laboratory Practices (GLP) certificate issued by the Food & Drugs Administration, Madhya Pradesh.

It has two manufacturing facilities in Indore, Madhya Pradesh.

Competitive Strengths

  • Multi-product capability and diversified product portfolio
  • Experienced promoters, management and employees.
  • Quality assurance
  • Established client relationship
Apply for This IPO
₹139
Min. ₹139,000 · 1,000 shares/lot
Expected Listing ₹141
GMP +₹2 (+1%)
Close Date 25 May 2026
Check Allotment
Pre-Issue
91,80,001 shares
Post-Issue
1,25,75,001 shares
Company Contact
Registrar
Skyline Financial Services Pvt.Ltd
  • 02228511022
  • ipo@skylinerta.com
Lead Managers
  • Narnolia Financial Services Ltd
Back to All IPOs